Bone Microstructure in Response to Vitamin D3 Supplementation: A Randomized Placebo-Controlled Trial

Area of Science:

• Endocrinology
• Bone Metabolism
• Nutritional Science

Background:

• Vitamin D is crucial for bone health, but its efficacy in preventing osteoporosis is debated.
• Low vitamin D levels and high parathyroid hormone (PTH) are common in postmenopausal women.
• The study investigates the impact of vitamin D3 supplementation on bone health markers.

Purpose of the Study:

• To assess the effect of 3-month daily vitamin D3 supplementation on bone health in postmenopausal women.
• To evaluate changes in bone turnover markers, bone mineral density (BMD), and bone microarchitecture.
• To determine if vitamin D3 supplementation improves bone strength and reduces osteoporosis risk.

Main Methods:

• A double-blinded, placebo-controlled randomized trial involving 81 healthy postmenopausal women.
• Participants received daily vitamin D3 (70 µg or 2800 IU) or placebo during winter months.
• Bone health was assessed using DXA, HRpQCT, QCT scans, and bone turnover markers.

Main Results:

• Vitamin D3 significantly increased 25(OH)D and 1,25(OH)2D levels and reduced PTH.
• No significant changes were observed in bone turnover markers or areal BMD (aBMD) by DXA.
• Vitamin D3 improved volumetric BMD (vBMD) in the trochanter and femoral neck.
• HRpQCT showed increased trabecular thickness and estimated bone strength (failure load, stiffness) in the tibia.
• Changes in 25(OH)D correlated with improvements in bone strength and trabecular thickness.

Conclusions:

• Three months of vitamin D3 supplementation enhances bone strength and vBMD in specific skeletal sites.
• Vitamin D3 supplementation effectively corrects vitamin D deficiency and suppresses PTH in postmenopausal women.
• While not affecting aBMD, vitamin D3 shows potential in improving bone microarchitecture and strength, warranting further investigation.